Revenue from Contracts with Customers (Tables)

9 Months Ended

Jun. 30, 2023

Revenue from Contract with Customer [Abstract]

Revenue by Reporting Unit

	Three months ended June 30,				Nine months ended June 30,
	2023		2022			2023	2022
Significant Business Line
Life Sciences Products, excluding B Medical	$	47,810	$	47,369	$	139,386	$	150,861
B Medical		26,761		-		83,705		-
Sample Repository Solutions		27,531		26,000		82,452		78,806
Genomic Services		63,846		59,366		187,172		188,264
Total revenue	$	165,948	$	132,735	$	492,715	$	417,931

Remaining Performance Obligations

	As of June 30, 2023
	Less than 1 Year		Greater than 1 Year		Total
Remaining performance obligations	$	62,778	$	24,654	$	87,432